tiprankstipranks
Gilead granted Breakthrough Therapy Designation for Trodelvy by FDA
The Fly

Gilead granted Breakthrough Therapy Designation for Trodelvy by FDA

Gilead (GILD) announced that the FDA has granted Breakthrough Therapy Designation to Trodelvy for the treatment of adult patients with extensive-stage small cell lung cancer, or ES-SCLC, whose disease has progressed on or after platinum-based chemotherapy.

Invest with Confidence:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App